Literature DB >> 26309560

Mutational analysis of CHRNB2, CHRNA2 and CHRNA4 genes in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy.

Zhihong Chen1, Lingan Wang2, Chun Wang1, Qian Chen1, Qiongxiang Zhai1, Yuxiong Guo1, Yuxin Zhang1.   

Abstract

OBJECTIVE: The present study aims to investigate the gene mutations of CHRNB2, CHRNA2 and CHRNA4 in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).
METHODS: 257 ADNFLE patients (74 sporadic and 32 familial) were collected, including 42 pedigree patients and 215 sporadic cases. Exon mutational screening of CHRNB2, CHRNA2 and CHRNA4 was performed by direct PCR sequencing.
RESULTS: No published mutations of CHRNB2, CHRNA4 and CHRNA2 genes were detected in this study. Three kinds of c.SNP (c.66C> T, c.249C> T, c.375A> G) were detected on the 2(nd) and 5(th) exons of CHRNA2; six kinds of c.SNP (c.639T> C, c.678T> C, c.1209G> T, c.1227T> C, c.1659G> A, c.1629C> T) were detected on the 5(th) exon of CHRNA4. Three novel mutations were discovered, respectively locating on the exon 5 of CHRNA4 gene (c.570C> T), 5(th) and 6(th) exons of CHRNB2 gene (c.483C> T and c.1407C> G). The three mutations were absent in 200 healthy controls, indicating that the mutations were very rare.
CONCLUSION: CHRNA4, CHRNB2 and CHRNA2 may be not the causative genes of Chinese ADNFLE population. Whether the three novel synonymous mutations were genetic factors of ADNFLE pathogenesis in Chinese Han population needs to be further studied.

Entities:  

Keywords:  CHRNA2 gene mutation; CHRNB2; Nocturnal frontal lobe epilepsy

Year:  2015        PMID: 26309560      PMCID: PMC4538063     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  A de novo mutation in sporadic nocturnal frontal lobe epilepsy.

Authors:  H A Phillips; C Marini; I E Scheffer; G R Sutherland; J C Mulley; S F Berkovic
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

2.  Mutation (Ser284Leu) of neuronal nicotinic acetylcholine receptor alpha 4 subunit associated with frontal lobe epilepsy causes faster desensitization of the rat receptor expressed in oocytes.

Authors:  Nobuaki Matsushima; Shinichi Hirose; Hiromi Iwata; Goryu Fukuma; Minako Yonetani; Chiaki Nagayama; Wakako Hamanaka; Yukiko Matsunaka; Masatoshi Ito; Sunao Kaneko; Akihisa Mitsudome; Hiroyuki Sugiyama
Journal:  Epilepsy Res       Date:  2002-02       Impact factor: 3.045

3.  Phenotypic comparison of two Scottish families with mutations in different genes causing autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Ailsa McLellan; Hilary A Phillips; Christopher Rittey; Martin Kirkpatrick; John C Mulley; David Goudie; John B P Stephenson; John Tolmie; Ingrid E Scheffer; Samuel F Berkovic; Sameer M Zuberi
Journal:  Epilepsia       Date:  2003-04       Impact factor: 5.864

Review 4.  Recent advances on autosomal dominant nocturnal frontal lobe epilepsy: "understanding the nicotinic acetylcholine receptor (nAChR)".

Authors:  G di Corcia; A Blasetti; M De Simone; A Verrotti; F Chiarelli
Journal:  Eur J Paediatr Neurol       Date:  2005       Impact factor: 3.140

5.  Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore.

Authors:  Jean-Charles Hoda; Wenli Gu; Marc Friedli; Hilary A Phillips; Sonia Bertrand; Stylianos E Antonarakis; David Goudie; Richard Roberts; Ingrid E Scheffer; Carla Marini; Jayesh Patel; Samuel F Berkovic; John C Mulley; Ortrud K Steinlein; Daniel Bertrand
Journal:  Mol Pharmacol       Date:  2008-05-02       Impact factor: 4.436

6.  A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  O K Steinlein; J C Mulley; P Propping; R H Wallace; H A Phillips; G R Sutherland; I E Scheffer; S F Berkovic
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

7.  Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Agata Rozycka; Elzbieta Skorupska; Andrzej Kostyrko; Wieslaw H Trzeciak
Journal:  Epilepsia       Date:  2003-08       Impact factor: 5.864

8.  A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.

Authors:  Tobias Leniger; Colette Kananura; Andreas Hufnagel; Sonia Bertrand; Daniel Bertrand; Ortrud K Steinlein
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864

9.  A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely.

Authors:  Wenli Gu; Daniel Bertrand; Ortrud K Steinlein
Journal:  Neurosci Lett       Date:  2007-06-08       Impact factor: 3.046

10.  Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear.

Authors:  Paolo Aridon; Carla Marini; Chiara Di Resta; Elisa Brilli; Maurizio De Fusco; Fausta Politi; Elena Parrini; Irene Manfredi; Tiziana Pisano; Dario Pruna; Giulia Curia; Carlo Cianchetti; Massimo Pasqualetti; Andrea Becchetti; Renzo Guerrini; Giorgio Casari
Journal:  Am J Hum Genet       Date:  2006-06-26       Impact factor: 11.025

View more
  3 in total

Review 1.  Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy.

Authors:  Feng Wei; Li-Min Yan; Tao Su; Na He; Zhi-Jian Lin; Jie Wang; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao
Journal:  Neurosci Bull       Date:  2017-05-09       Impact factor: 5.203

Review 2.  Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology.

Authors:  Andrea Becchetti; Laura Clara Grandi; Giulia Colombo; Simone Meneghini; Alida Amadeo
Journal:  Brain Sci       Date:  2020-11-25

3.  Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells.

Authors:  Mitsuro Kanda; Dai Shimizu; Shunsuke Nakamura; Koichi Sawaki; Shinichi Umeda; Takashi Miwa; Haruyoshi Tanaka; Yoshikuni Inokawa; Norifumi Hattori; Masamichi Hayashi; Chie Tanaka; Goro Nakayama; Yohei Iguchi; Masahisa Katsuno; Yasuhiro Kodera
Journal:  Oncogene       Date:  2021-07-30       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.